Biotechnology News

Company announcement no. 29 – 2610 August 2026 NTG Nordic Transport Group publishes interim report for H1 2026The interim report for H1 2026 is enclosed. In connection with publication of the...

Six new Genome BC supported projects use integrated genomic and health data to explore earlier diagnosis, personalized care and better outcomes.

BELTSVILLE, Md., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Xcellon Biologics, a U.S.-based Contract Research, Development and Manufacturing Organization (CRDMO) specializing in bioconjugates and complex...

Investigator-led study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinical potential into ophthalmology Initial DREAM Study Results Anticipated in Q4 2026 SOLANA BEACH,...

Applied Biologics highlights CMS 2027 proposed rule recognizing the FDA's Section 351 biologic regulatory pathway.

CAMBRIDGE, Mass., Aug. 10, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (NASDAQ: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to...

SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare...

SPY772 program aims to deliver best-in-indication efficacy and convenience in Hidradenitis Suppurativa through dual inhibition of TL1A and IL-17A/F in a long-acting coformulation Phase 2 SKYLIGHT...

SAN DIEGO, Aug. 10, 2026 (GLOBE NEWSWIRE) -- Erasca, Inc. (Nasdaq: ERAS), a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for...

REYKJAVÍK (10. ágúst 2026) – Alvotech (NASDAQ: ALVO) mun birta uppgjör fyrri árshelmings 2026 þann 19. ágúst nk., eftir lokun markaða í Bandaríkjunum. Fundur til kynningar á uppgjörinu verður sendur...